Plasma and urinary levels of “urotensin (U)-II-like” substances determined in healthy human
volunteers were 12.4±0.6 ng/ml and 2.2±0.3 ng/ml by RIA, an order of magnitude lower than …

Objectives: The aim of this study is to determine urotensin-II (U-II) levels in obese children
and adolescents with metabolic syndrome (MS) compared to obese children and …

Objective: To verify the relationship between Urotensin II (UII) gene and serum levels and
pre-eclampsia (PE). Study Design: Prospective case control study. Setting: Tertiary Obstetric …

Aim: Urotensin II (UII) and its system is implicated in the etiology of many diseases (including
diabetes mellitus). We tried in this study to evaluate and compare UII levels in gestational …

BACKGROUND: UII is elevated in patients with heart failure; however its role in acute
myocardial infarction (AMI) is unknown. We sought to compare levels of UII in patients with …

OBJECTIVE: To investigate the changes of plasma urotensinII (UII) levels in patients with
congestive heart failure (CHF) of different severities and their clinical implications …

Abstract Urotensin-II (UII), a pluripotent vasoactive cyclic peptide, exhibits the progression of
cardiovascular diseases and the glucose metabolic disorder of insulin resistance. Type 2 …

Results: In patients with the highest risk (TIMI 5-7) plasma UII concentration was significantly
lower than in those with low risk (TIMI 1-2): 2.61±1.47 ng/ml vs. 3.60±2.20 ng/ml …

Background: The sources of secretion and clearance of plasma urotensin II (UII) in the
human circulation remain uncertain and may be relevant to understanding the role of UII in …

ABSTRACT Changes in Urotensin-II (U-II) concentration, a potent vasoconstrictor peptide,
have been detected in various pathologies, but it has been impossible to define a normality …